TG Therapeutics, Inc. (TGTX)
63.38
+3.56
(+5.94%)
USD |
NASDAQ |
Nov 09, 16:00
63.28
-0.10
(-0.16%)
Pre-Market: 09:09
TG Therapeutics Cash and Short Term Investments (Quarterly) : 556.71M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 556.71M |
| June 30, 2026 | 552.25M |
| March 31, 2026 | 514.43M |
| December 31, 2025 | 141.97M |
| September 30, 2025 | 131.58M |
| June 30, 2025 | 251.87M |
| March 31, 2025 | 276.24M |
| December 31, 2024 | 311.00M |
| September 30, 2024 | 341.04M |
| June 30, 2024 | 217.25M |
| March 31, 2024 | 209.78M |
| December 31, 2023 | 217.51M |
| September 30, 2023 | 229.16M |
| June 30, 2023 | 144.90M |
| March 31, 2023 | 139.71M |
| December 31, 2022 | 161.68M |
| September 30, 2022 | 175.94M |
| June 30, 2022 | 195.71M |
| March 31, 2022 | 233.20M |
| December 31, 2021 | 314.76M |
| September 30, 2021 | 356.85M |
| June 30, 2021 | 443.46M |
| March 31, 2021 | 523.85M |
| December 31, 2020 | 605.43M |
| September 30, 2020 | 254.15M |
| Date | Value |
|---|---|
| June 30, 2020 | 275.57M |
| March 31, 2020 | 78.34M |
| December 31, 2019 | 140.44M |
| September 30, 2019 | 72.45M |
| June 30, 2019 | 84.98M |
| March 31, 2019 | 92.47M |
| December 31, 2018 | 68.81M |
| September 30, 2018 | 97.74M |
| June 30, 2018 | 126.24M |
| March 31, 2018 | 109.08M |
| December 31, 2017 | 84.72M |
| September 30, 2017 | 91.84M |
| June 30, 2017 | 86.41M |
| March 31, 2017 | 109.46M |
| December 31, 2016 | 44.89M |
| September 30, 2016 | 60.60M |
| June 30, 2016 | 54.26M |
| March 31, 2016 | 58.70M |
| December 31, 2015 | 77.23M |
| September 30, 2015 | 94.16M |
| June 30, 2015 | 92.07M |
| March 31, 2015 | 105.14M |
| December 31, 2014 | 78.78M |
| September 30, 2014 | 67.24M |
| June 30, 2014 | 45.04M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 171.57M |
| Vertex Pharmaceuticals, Inc. | 6.313B |
| Regeneron Pharmaceuticals, Inc. | 9.314B |
| SELLAS Life Sciences Group, Inc. | 138.44M |
| Travere Therapeutics, Inc. | 471.82M |